Osteoporosis Clinical Trials in San Antonio

Showing 41-45 of 45 trials

A Study to Evaluate the Effects of SB-751689 or rhPTH(1-34) on Excretion of Calcium and Phosphate in Women

NCT00532077

SB-751689 may alter calcium and phosphate handling at the kidney level. This study will examine what happens to calcium and phosphate, and other electrolytes, at the kidney after treatment with SB-751689 for 1 month. Another group of subjects will get another drug called Forteo for 1 month to compare the response of the kidney for calcium and phosphate.

Osteoporosis

GlaxoSmithKline40 participantsStarted Aug 2007

San Diego, California, United States • Daytona Beach, Florida, United States • Port Orange, Florida, United States +2 more locations

COMPLETEDPhase 3190 miles

Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis

NCT00383422

The purpose of this study is to compare the effect of arzoxifene to raloxifene on the bone mineral density (bone strength).

Osteoporosis, Postmenopausal

Eli Lilly and Company320 participantsStarted Oct 2006

Gainesville, Georgia, United States • Urbandale, Iowa, United States • Billings, Montana, United States +18 more locations

A Study to Evaluate the Effects of SB-751689 or rhPTH(1-34) on Excretion of Calcium and Phosphate in Women

Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis

Osteoporosis Trials in Other Cities

Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis

Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis

Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis

Other Conditions in San Antonio